Organogenesis Holdings (ORGO) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to -$68.1 million.
- Organogenesis Holdings' Enterprise Value rose 2824.94% to -$68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.1 million, marking a year-over-year increase of 2824.94%. This contributed to the annual value of -$136.2 million for FY2024, which is 3049.03% down from last year.
- Latest data reveals that Organogenesis Holdings reported Enterprise Value of -$68.1 million as of Q3 2025, which was up 2824.94% from -$78.4 million recorded in Q2 2025.
- Over the past 5 years, Organogenesis Holdings' Enterprise Value peaked at -$487000.0 during Q3 2021, and registered a low of -$136.2 million during Q4 2024.
- Its 5-year average for Enterprise Value is -$84.5 million, with a median of -$94.9 million in 2024.
- In the last 5 years, Organogenesis Holdings' Enterprise Value crashed by 2208090.35% in 2022 and then skyrocketed by 2824.94% in 2025.
- Over the past 5 years, Organogenesis Holdings' Enterprise Value (Quarter) stood at -$114.5 million in 2021, then increased by 9.81% to -$103.3 million in 2022, then fell by 1.01% to -$104.3 million in 2023, then plummeted by 30.49% to -$136.2 million in 2024, then soared by 49.97% to -$68.1 million in 2025.
- Its Enterprise Value stands at -$68.1 million for Q3 2025, versus -$78.4 million for Q2 2025 and -$117.0 million for Q1 2025.